Adjustment For Social Risk Factors Does Not Meaningfully Affect Performance On Medicare's MIPS Clinician Cost

Alexander T Sandhu1, Jay Bhattacharya2, Joyce Lam3

  • 1Alexander T. Sandhu (ats114@stanford.edu) is an instructor in the Department of Medicine at Stanford University, in Stanford, California. He is also a health policy consultant at Acumen, LLC, in Burlingame, California.

Insights

Medicare

Area of Science:

  • Health economics
  • Health services research

Background:

  • Medicare's Merit-based Incentive Payment System (MIPS) uses episode-based cost measures to assess clinician performance.
  • These measures influence Medicare Part B payments but lack social risk factor adjustment.
  • Previous studies indicated higher healthcare costs associated with increased social risk.

Purpose of the Study:

  • To determine if adjusting for social risk factors impacts clinician performance on MIPS episode-based cost measures.
  • To evaluate if MIPS cost measures unfairly penalize clinicians serving high-social-risk populations.

Main Methods:

  • Analysis of Medicare's episode-based cost measures.
  • Inclusion of individual and community social risk factors in the analysis.
  • Assessment of changes in clinician cost measure performance percentiles before and after risk adjustment.

Main Results:

  • Adjusting for social risk factors had a minimal impact on clinician cost measure performance.
  • On average, only 1.4% of clinician groups experienced a significant performance change (≥10 percentile points).
  • MIPS episode-based cost measures showed similar costs for patients with high and low social risk, suggesting no inherent penalty.

Conclusions:

  • Medicare's episode-based cost measures appear robust to social risk factor adjustment.
  • These measures do not seem to disadvantage clinicians caring for patients with higher social risk.
  • The specific design of MIPS cost measures, focusing on condition-related costs, may explain these findings.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
105
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
297
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.1K
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
764
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
6.0K
Mismatch Repair01:36

Mismatch Repair

Overview
43.1K